Evaluating the association between cognitive impairment and striatal VMAT2 binding using [18F]AV-133 PET in Parkinson’s disease
Objective: To evaluate the association between cognitive deficits and striatal vesicular monoamine transporter type 2 (VMAT2) binding in participants with Parkinson’s disease (PD) using [18F]AV-133…Serotonergic dysfunction and impulse control disorders in Parkinson’s disease: a double-tracer PET study
Objective: To investigate the dysfunction of the serotonergic system related to impulse control disorders in patients with Parkinson’s disease. Background: Impulse control disorders (ICDs, including…Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg
Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…Sustained Effect of Posteroventral Pallidotomy for X-Linked Dystonia Parkinsonism
Objective: To determine the effects of Posteroventral Pallidotomy in two patients with X-Linked Dystonia Parkinsonism in the Philippines Background: X-linked dystonia parkinsonism (XDP, DYT3), a disease…Patient Experience during Automated Deep Brain Stimulation (DBS) Changing for Sleep (PEACe study)
Objective: To evaluate the feasibility of an automated intermittent deep brain stimulation (DBS) sleep program in essential tremor (ET) patients with ventralis intermedius nucleus (VIM)…Safety and effectiveness of staged bilateral MR-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson’s disease: study protocol
Objective: To describe the protocol of a study evaluating the safety and effectiveness of magnetic resonance-guided focused ultrasound (MRgFUS) pallidothalamic tractotomy (PTT) as a staged…Dopamine Dysregulation Syndrome Outcomes following Pallidal Deep Brain Stimulation in Parkinson’s Disease
Objective: To examine the impact of pallidal deep brain stimulation (DBS) on symptoms of Dopamine Dysregulation Syndrome (DDS) in Parkinson’s disease (PD). Background: DDS is…Clinical Correlation of Double Oscillatory Peaks in Parkinson’s Disease with Deep Brain Stimulation
Objective: To investigate clinical characteristics of Parkinson’s disease (PD) with deep brain stimulation, who demonstrated local field potential (LFP) with double peaks. Background: Beta frequency…Imaging-based Troubleshooting Deep Brain Stimulation in Parkinson’s Disease
Objective: Evaluate whether if electrodes reconstruction using Lead-DBS, an open source toolbox, in patients with Parkinson’s Disease (PwPDP) treated with Deep Brain Stimulation (DBS) presenting…The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)
Objective: To develop a better understanding of the current use of consumer and medical wearable monitoring devices in the clinical management of PD and to…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 181
- Next Page »
